Literature DB >> 8134131

Functional dissection of the transcription factor Elk-1.

R Janknecht1, R Zinck, W H Ernst, A Nordheim.   

Abstract

The ternary complex factor Elk-1 belongs to the Ets oncoprotein family. We demonstrate that this transcription factor is localized predominantly in the nucleus, for which at least two regions of Elk-1 are required. One of these regions is part of the N-terminal ETS-domain, while the other encompasses amino acids 137-157. In conjunction with the ETS-domain, which mediates autonomous binding of Elk-1 to some DNA target sequences, the conserved B-region is both necessary and sufficient for ternary complex formation with the c-fos serum response element and the serum response factor. However, the B-region must be linked to the ETS-domain by a spacer. Furthermore, the B-region impedes autonomous DNA-binding, possibly by masking the ETS-domain. A point mutation within the ETS-domain, homologous to the ts1.1 point mutation of v-Ets in the E26 virus, affects DNA-binding of Elk-1 in a temperature-dependent manner, which by analogy might be causative for the altered phenotype of ts1.1 E26. Finally we show that amino acids 83-428 contribute to Elk-1 mediated transactivation. In particular, the region 376-404 is indispensable for transactivation, while flanking amino acids on both sides are only required for enhancement of transcriptional efficacy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134131

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.

Authors:  S H Yang; E Vickers; A Brehm; T Kouzarides; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  The ETS domain transcription factor Elk-1 contains a novel class of repression domain.

Authors:  Shen-Hsi Yang; Donna C Bumpass; Neil D Perkins; Andrew D Sharrocks
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

3.  Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.

Authors:  Luciano De Haro; Ralf Janknecht
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

4.  The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.

Authors:  Jason D Prescott; Karen S N Koto; Meenakshi Singh; Arthur Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

5.  Analysis of the ERK-stimulated ETS transcription factor ER81.

Authors:  R Janknecht
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain.

Authors:  V Sgambato; P Vanhoutte; C Pagès; M Rogard; R Hipskind; M J Besson; J Caboche
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

7.  Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties.

Authors:  E Valjent; J C Corvol; C Pages; M J Besson; R Maldonado; J Caboche
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

8.  Molecular characterization of the B-box protein-protein interaction motif of the ETS-domain transcription factor Elk-1.

Authors:  Y Ling; J H Lakey; C E Roberts; A D Sharrocks
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

9.  Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1.

Authors:  Kasumi Murai; Richard Treisman
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Specific and differential activation of mitogen-activated protein kinase cascades by unfamiliar taste in the insular cortex of the behaving rat.

Authors:  D E Berman; S Hazvi; K Rosenblum; R Seger; Y Dudai
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.